17:02 , Feb 6, 2018 |  BC Innovations  |  Distillery Therapeutics

Infectious disease

INDICATION: Tuberculosis Non-human primate studies suggest a vaccine based on cytomegalovirus (CMV) expressing six M. tuberculosis antigens could help prevent tuberculosis (TB). The vaccine consists of six bacterial antigens -- M. tuberculosis fbpA, esxA, vapB47,...
18:33 , Mar 8, 2017 |  BC Innovations  |  Distillery Therapeutics

Other

INDICATION: Adjuvant Cell culture and mouse studies suggest a synthetic glycolipid adjuvant could help improve the efficacy of vaccines for infectious diseases with less toxicity than conventional adjuvants. In human monocytes and mouse monocyte-derived dendritic...
19:18 , Mar 2, 2017 |  BC Innovations  |  Translation in Brief

Polyester protection

A vaccine based on engineered biobeads offers a new paradigm for immunization against tuberculosis that incorporates both known and unknown antigens to mimic the broad repertoire of live vaccines, but with the safety of non-infectious...